Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-021243
Filing Date
2024-08-13
Accepted
2024-08-13 18:05:04
Documents
1
Period of Report
2024-08-12

Document Format Files

Seq Description Document Type Size
1 form4-08132024_060801.html 4  
1 form4-08132024_060801.xml 4 6474
  Complete submission text file 0001415889-24-021243.txt   7965
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O HORIZON THERAPEUTICS, INC. 2 TOWER PLACE, 12TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Thompson Elizabeth H.Z. (Reporting) CIK: 0001861477 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 241203418